SEC 13F Intelligence

Altium Capital Management LLC / ZVRA

Altium Capital Management LLC’s Zevra Therapeutics Inc Position

Does Altium Capital Management LLC own Zevra Therapeutics Inc (ZVRA)? Not currently — the last reported position was 1.29M shares worth $10M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q1 2025
Shares
1.29M
% of Portfolio
+23.23%
Quarters Held
5
position exited

Position History ZVRA

Reported value by quarter
Q1 ’24: $2MQ1 ’24Q2 ’24: $6MQ2 ’24Q3 ’24: $12MQ3 ’24Q4 ’24: $15MQ4 ’24Q1 ’25: $10MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20251.29M$10M+23.23%
Q4 20241.85M$15M+4.38%
Q3 20241.70M$12M+3.47%
Q2 20241.16M$6M+2.32%
Q1 2024341.5K$2M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ZVRA.